NCT04874467

Brief Summary

Introduction: It seems that some local and systemic factors can be associated with an increased incidence of peri-implant diseases. Predisposing to an increase inflammatory response when plaque is present. There is still controversy on which factors can be considered as risk indicators. One of them is the keratinized mucosa width (KM), that seems to facilitate plaque control around implants. Objectives: Assess the relationship between keratinized mucosa and the recurrence of mucositis, comparing bleeding on probing (BOP) in implants with mucositis for 24 weeks after implant disinfection therapy, the control group is defined by having KM ≥ 2 mm and the test group KM \< 2 mm. Material and methods: 38 patients presenting one single implant each with a single screw retained crown loaded for at least 1 year. Periodontal maintenance therapy will be performed and oral hygiene instruction will be delivered. Follow up visits will be after 8, 12 and 24 weeks in which the following parameters will be registered: Keratinized Mucosa width, Attached mucosa, Gingival Index, Vestibule Depth, Mucosa Thickness. Probing Pocket Depth, Recession, modified Plaque Index, Bleeding on Probing, modified Bleeding Index. Also a microbiologic test will be taken in the implant sulcus before the periodontal maintenance therapy and at 24 weeks. A multilevel statistical analysis will be conducted comparing the control and the test group, adjusting for the correlation among multiple observations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 30, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2022

Completed
Last Updated

August 9, 2022

Status Verified

August 1, 2022

Enrollment Period

1.6 years

First QC Date

April 30, 2021

Last Update Submit

August 6, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bleeding on probing

    The main objective of the study is to evaluate the association between MQ and recurrence of mucositis, comparing the bleeding index on probing (BoP) in implants that have mucositis, in a control group characterized by 2 mm or more of MQ and a test group characterized by less than 2 mm of MQ over a 24-week period after peri-implant maintenance therapy.

    24 weeks

Study Arms (2)

Keratinized Mucosa ≥ 2 mm

EXPERIMENTAL

Supportive periodontal therapy, in teeth by means of ultrasonic devices and manual curettes. In implants using the same devices but made of titanium. Oral hygiene instructions

Procedure: Supportive periodontal therapy

Keratinized Mucosa < 2 mm

EXPERIMENTAL

Supportive periodontal therapy, in teeth by means of ultrasonic devices and manual curettes. In implants using the same devices but made of titanium. Oral hygiene instructions

Procedure: Supportive periodontal therapy

Interventions

A complete professional prophylaxis session will be performed, which includes ultrasound debridement, scaling with curettes and dental polishing with a rubber cup. On the other hand, in implants affected by mucositis, supra and sub-gingival debridement will be performed using a combination of ultrasound with a titanium tip and titanium curettes. All patients will receive personalized hygiene instructions. Patients will be instructed to brush their implants twice daily using the modified Bass technique with a medium-hard manual toothbrush and low-abrasive toothpaste. In addition, they will be taught to use specific interproximal brushes. If access with an interdental brush is not possible, flossing will be indicated. Oral hygiene instructions will be reviewed at each visit.

Keratinized Mucosa < 2 mmKeratinized Mucosa ≥ 2 mm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients\> 18 years;
  • smokers \<10 cigarettes / day;
  • partially edentulous patients. The spaces must be associated with at least one adjacent mesial and one distal tooth;
  • presence of bleeding and / or suppuration on probing, erythema and inflammation;
  • absence of radiographic bone loss around implant distance (\<2mm from expected radiographic marginal bone level);
  • individual dental implants rehabilitated for more than a year;
  • screw-retained restorations on implants;
  • absence of active periodontal disease;
  • who have not taken systemic antibiotics in the last 3 months;
  • adequate oral hygiene motivation and collaboration defined as plaque index \<25%

You may not qualify if:

  • totally edentulous patients;
  • uncontrolled systemic diseases;
  • diseases of the mucosa (erosive lichen planus, etc.);
  • taking medications that may interfere with periodontal health or healing; (corticosteroids, calcium channel antagonists, antiepileptic drugs, immunosuppressants, etc.)
  • pregnant or lactating patients;
  • cemented implant restorations;
  • restorations on implants over contoured that cannot be corrected.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

International University of Catalunya

Barcelona, 08172, Spain

Location

Related Publications (1)

  • Blasi G, Chierico F, Amerio E, Alvarez G, Isabal S, Arredondo A, Blanc V, Nart J, Monje A. Influence of keratinized mucosa width on the resolution of peri-implant mucositis: A prospective cohort study. Clin Implant Dent Relat Res. 2024 Jun;26(3):581-591. doi: 10.1111/cid.13317. Epub 2024 Mar 1.

MeSH Terms

Conditions

Peri-ImplantitisPatient Compliance

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Jose Nart, DDS PhD

    Universitat Internacional de Catalunya

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Instructor

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 5, 2021

Study Start

September 1, 2020

Primary Completion

April 25, 2022

Study Completion

April 25, 2022

Last Updated

August 9, 2022

Record last verified: 2022-08

Locations